Management and prevention of anemia (acute bleeding excluded) in adult critical care patients
Sigismond Lasocki(Centre Hospitalier Universitaire d'Angers), Gérald Chanques(Université de Montpellier), Olivier Huet(Baker Heart and Diabetes Institute), Thomas Lescot(Sorbonne Université), Sylvain Ausset(École Spéciale Militaire de Saint-Cyr), Pierre Buffet(Hôpital Necker-Enfants Malades), Michaël Piagnerelli, Cécile Aubron(Université de Bretagne Occidentale), Frédéric Pène(Centre National de la Recherche Scientifique), Antoine Kimmoun(Imation (United States)), Matthieu Legrand(University of California, San Francisco), Lionel Velly(Centre National de la Recherche Scientifique), Hafid Ait‐Oufella(Inserm), Hervé Quintard, Yoann Launey(Société Française d'Allergologie), Armand Mekontso Dessap(Université Paris-Est Créteil)
Cited by 63
Related Papers
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
|JAMA Internal Medicine|2020|777
Rapidly Progressive Diaphragmatic Weakness and Injury during Mechanical Ventilation in Humans
|American Journal of Respiratory and Critical Care Medicine|2010|723
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
|Nature Reviews Nephrology|2020|703